Safety and Efficacy of the Phototherapeutic Keratectomy for Treatment of Recurrent Corneal Erosions: A Systematic Review and Meta-Analysis

Abstract

<b><i>Background:</i></b> Phototherapeutic keratectomy (PTK) has been increasingly used to treat severe recurrent corneal erosion syndrome (RCES) patients who do not respond to other treatments. However, the efficacy and complication of each study are currently uncertain due to varying rates. <b><i>Objectives:</i></b> The objective of this study was to investigate the safety and efficacy of the PTK for recurrent corneal erosions. <b><i>Methods:</i></b> This article performed a systematic literature research in Cochrane, Embase, PubMed, Scopus, and the Web of Science for the literature on PTK treatment of RCES until December 20, 2022. The extracted data including recurrence rate and the adverse event rate were used for meta-analysis. <b><i>Results:</i></b> The recurrence rate was 18% (95% CI, 13%–24%) (129/700 eyes). Subgroup analysis showed that the RCE recurrence was 17% (95% CI, 9%–24%) after trauma and 22% (95% CI, 11%–32%) in the corneal dystrophy group. Treatment-related adverse events included subepithelial haze, hyperopic shift, and decrease of the best spectacle-corrected visual acuity. In this study, the incidence of these events was 13% (95% CI, 6%–21%), 20% (95% CI, 11%–28%), and 11% (95% CI, 5%–16%), respectively. <b><i>Conclusions:</i></b> PTK represented a valuable treatment option for patients with recurrent corneal erosions, especially those with traumatic injuries, which had minimal side effects.